当前位置:首页 - 行情中心 - 森萱医药(830946) - 财务分析 - 现金流量表

森萱医药

(830946)

  

流通市值:48.65亿  总市值:48.67亿
流通股本:4.27亿   总股本:4.27亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金258,716,727.94129,119,793.5488,822,885.77354,957,753.01
  收到的税费返还36,555.031,190.42211,319.03161,370.32
  收到其他与经营活动有关的现金6,754,615.732,885,755.4631,219,567.323,795,664.11
  经营活动现金流入小计265,507,898.7132,006,739.38520,253,772.1378,914,787.44
  购买商品、接受劳务支付的现金72,934,950.5938,263,140.13160,897,362.76118,353,385.83
  支付给职工以及为职工支付的现金60,450,988.0834,648,036.02112,122,170.5485,647,985.27
  支付的各项税费28,325,038.415,076,868.1547,358,011.0937,403,940.43
  支付其他与经营活动有关的现金11,597,711.124,974,347.1128,618,939.921,070,587.14
  经营活动现金流出小计173,308,688.1992,962,391.41348,996,484.29262,475,898.67
  经营活动产生的现金流量净额92,199,210.5139,044,347.97171,257,287.81116,438,888.77
二、投资活动产生的现金流量:
  收回投资收到的现金150,000,00030,000,000245,000,000175,000,000
  取得投资收益收到的现金795,663.8760,834.763,855,326.433,303,271.63
  处置固定资产、无形资产和其他长期资产收回的现金净额--80,000-
  收到的其他与投资活动有关的现金--44,223,322.2244,223,322.22
  投资活动现金流入小计150,795,663.8730,060,834.76293,158,648.65222,526,593.85
  购建固定资产、无形资产和其他长期资产支付的现金4,216,456.812,257,726.6620,445,432.1119,197,245.27
  投资支付的现金228,000,000112,000,000165,000,00080,000,000
  支付其他与投资活动有关的现金71,000,000-110,000,000-
  投资活动现金流出小计303,216,456.81114,257,726.66295,445,432.1199,197,245.27
  投资活动产生的现金流量净额-152,420,792.94-84,196,891.9-2,286,783.46123,329,348.58
三、筹资活动产生的现金流量:
  收到其他与筹资活动有关的现金--259,039.78-
  筹资活动现金流入平衡项目--0-
  筹资活动现金流入小计--259,039.78-
  偿还债务支付的现金--20,000,00016,000,000
  分配股利、利润或偿付利息支付的现金62,968,567.6-70,801,128.8370,772,239.94
  其中:子公司支付给少数股东的股利、利润3,200,000---
  支付其他与筹资活动有关的现金1,134,635.69269,659.981,744,071.52-
  筹资活动现金流出小计64,103,203.29269,659.9892,545,200.3586,772,239.94
  筹资活动产生的现金流量净额-64,103,203.29-269,659.98-92,286,160.57-86,772,239.94
四、汇率变动对现金及现金等价物的影响-368,779.14-27,264.021,920,250.1-352,560.94
五、现金及现金等价物净增加额-124,693,564.86-45,449,467.9378,604,593.88152,643,436.47
  加:期初现金及现金等价物余额583,318,157.66583,318,157.66504,713,563.78504,713,563.78
  期末现金及现金等价物余额458,624,592.8537,868,689.73583,318,157.66657,357,000.25
补充资料:
  净利润70,038,266.11-125,658,087.64-
  资产减值准备4,368,596.75-8,250,382.13-
  固定资产和投资性房地产折旧22,360,315.9-43,595,684.46-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧22,360,315.9-43,595,684.46-
  无形资产摊销582,160.97-1,201,335.69-
  处置固定资产、无形资产和其他长期资产的损失-4,478.7-190,269.32-
  固定资产报废损失--578,401.13-
  公允价值变动损失-854,982.69--1,464,962.91-
  财务费用-1,142,872.2--3,425,384.94-
  投资损失-420,272.41--1,198,523.11-
  递延所得税136,840.82--2,141,505.08-
  其中:递延所得税资产减少28,968.45--284,972.02-
    递延所得税负债增加107,872.37--1,856,533.06-
  存货的减少-7,593,142.06-17,992,507.63-
  经营性应收项目的减少8,223,198.9--17,788,879.17-
  经营性应付项目的增加-6,733,774.19--4,154,485.28-
  其他3,516,475.4--85,800.88-
  不涉及现金收支的投资和筹资活动金额其他项目123,309.6-435,502.16-
  现金的期末余额458,624,592.8-583,318,157.66-
  减:现金的期初余额583,318,157.66-504,713,563.78-
  现金及现金等价物的净增加额-124,693,564.86-78,604,593.88-
公告日期2025-08-292025-04-292025-04-142024-10-29
审计意见(境内)标准无保留意见
TOP↑